Notify me when Ho Chi Sing files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CASI | CASI Pharmaceuticals, Inc. | Ordinary Shares, par value US$0.0001 per share | 4.8% | $754,405 | 992,638 | 0% | Zhou Quan | 30 Sep 2025 | |
| PONY | Pony AI Inc. | Class A ordinary shares, par value US$0.0005 per share | 4.3% | $343,510,641 | -$66,897,472 | 15,273,928 | -16% | IDG China Venture Capital Fund IV L.P. | 30 Sep 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|